Image

    Scalp Cooling Has No Place in the Prevention of Alopecia in Adjuvant Chemotherapy for Breast Cancer

    January 1994 in “ European Journal of Cancer
    Robert A.E.M. Tollenaar, Gerrit‐Jan Liefers, O.J. Repelaer van Driel, Cornelis J.H. van de Velde
    Studysummary In this study, scalp hypothermia with the Theracool™ cooling machine was largely ineffective for preventing alopecia in breast cancer patients undergoing a chemotherapeutic regimen including cyclophosphamide and anthracyclines.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejcancer.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Prevention of Doxorubicin-Induced Alopecia by Scalp Hypothermia: Relation to Degree of Cooling The BMJ · 1982

    Related research 5

    1. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    2. Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus Case Reports in Dermatology · 2017
    3. The Use of Scalp Cooling for Chemotherapy-Induced Hair Loss British journal of nursing · 2016
    4. Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan International Journal of Trichology · 2013
    5. Scalp Cooling Has No Place in the Prevention of Alopecia in Adjuvant Chemotherapy for Breast Cancer European Journal of Cancer · 1994